Low pulse oximeter-measured hemoglobin oxygen saturations with hemoglobin Cheverly
β Scribed by Hohl, Raymond J.; Sherburne, Alan R.; Feeley, James E.; Huisman, Titus H. J.; Burns, C. Patrick
- Book ID
- 101215371
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 45 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Unexpectedly low hemoglobin oxygen saturation as determined by pulse-oximeter analysis was observed in a patient who underwent an elective surgical procedure. Specific hemoglobin derivatives such as carboxyhemoglobin, methemoglobin, and reduced hemoglobin that have been described to lower pulse-oximetry determination of oxygenation were not detected. Absorbance spectra revealed the patient's hemoglobin to be different than that obtained from two normal volunteers. High-pressure liquid chromatographic analysis of the hemoglobin showed an unknown band that comprised 15% of the patient's hemoglobin. DNA sequence analysis showed a point mutation in the second nucleotide of the 45th codon of the β€-globin chain. This mutation encodes for an abnormal β€-chain (β€-45 PheβSer) that has been described as hemoglobin Cheverly. Hemoglobin Cheverly is an unstable hemoglobin that has a similar mutation as the β€-42 PheβSer mutation seen in hemoglobin Hammersmith. Hemoglobin Hammersmith and another unstable hemoglobin, hemoglobin Ko Β¨ln, have previously been described to have unexpectedly low pulse-oximeter-determined oxyhemoglobin levels. That we find hemoglobin Cheverly to result in a similar phenomenon suggests that pulse-oximeter monitoring of oxygenation status may not be appropriate for the unstable hemoglobins. Low pulseoximeter oxygenation determinations for these hemoglobins do not appear to predict clinical hypoxemia. Am.
π SIMILAR VOLUMES
Pulse oximetry estimates arterial blood oxygen saturation based on light absorbance of oxy-and deoxy-hemoglobin at 660 and 940 nm wavelengths. Patients with unexpectedly low SpO 2 often undergo cardio-pulmonary testing to ascertain the cause of their hypoxemia. However, in a subset of patients, a va
Pulse oximetry is a noninvasive method of measuring oxyhemoglobin saturation. The validity of pulse oximetry in sickle cell disease (SCD) has been questioned. We evaluated pulse oximetry, arterial blood gas analysis, and co-oximetry in patients with SCD, and we assessed the effect of dyshemoglobin a
Pulse oximetry estimates arterial blood oxygen saturation based on light absorbance of oxy-and deoxy-hemoglobin at 660 and 940 nm wavelengths. Patients with unexpectedly low SpO 2 often undergo cardio-pulmonary testing to ascertain the cause of their hypoxemia. However, in a subset of patients, a va